8-KThe WireRoutine
Shareholder Vote
Filed Jun 22, 2026 · 8d ago · Accession 0001517022-26-000043
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Akebia Therapeutics, Inc.
- Ticker
- AKBA
- CIK
- 1517022
- Form type
- 8-K
- Filing date
- Jun 22, 2026
- Report date
- Jun 17, 2026
- Document
- akba-20260617.htm
- Size
- 177 KB